These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 1825799)

  • 61. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B].
    Coz Yataco A; Lozano Miranda A; Samalvides Cuba F; Antunez de Mayolo Ramis E
    Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria.
    Odusanya OO; Alufohai FE; Meurice FP; Wellens R; Weil J; Ahonkhai VI
    Int J Infect Dis; 2005 May; 9(3):139-43. PubMed ID: 15840454
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatitis B vaccine in pregnancy: immunogenicity, safety and transfer of antibodies to infants.
    Ayoola EA; Johnson AO
    Int J Gynaecol Obstet; 1987 Aug; 25(4):297-301. PubMed ID: 2887464
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effect of concurrent use of hepatitis B and Bacille Calmette-Guérin vaccination on anti-hepatitis B response.
    Artan R; Erol M; Velipasaoglu S; Yegin O
    Saudi Med J; 2004 Dec; 25(12):1939-42. PubMed ID: 15711671
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up].
    Zhang L; Lyu J; Yan B; Liu J; Feng Y; Chen S; Zhou L; Liang X; Cui F; Wang F; Xu A
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):782-7. PubMed ID: 26733135
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A cross-sectional serosurvey on hepatitis B vaccination uptake among adult patients from GP practices in a region of South-West Poland.
    Ganczak M; Dmytrzyk-Daniłów G; Korzeń M; Szych Z
    BMC Public Health; 2015 Oct; 15():1060. PubMed ID: 26475167
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatitis B immunisation rates among infants in ethnic groups with high prevalences of hepatitis B surface antigen carriers.
    Oman KM; Carnie J; Ruff TA
    Aust N Z J Public Health; 1997 Jun; 21(3):293-6. PubMed ID: 9270156
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatitis B immunisation with a reduced number of doses in newborn babies and children.
    Piazza M; Picciotto L; Villari R; Guadagnino V; Orlando R; Isabella L; Macchia V; Memoli AM; Vegnente A; Borrelli AM
    Lancet; 1985 Apr; 1(8435):949-51. PubMed ID: 2859412
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand.
    Chunsuttiwat S; Biggs BA; Maynard J; Thamapalo S; Laoboripat S; Bovornsin S; Charanasri U; Pinyowiwat W; Kunasol P
    Vaccine; 1997; 15(6-7):769-74. PubMed ID: 9178480
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepatitis B vaccination.
    Coutinho RA
    J Virol Methods; 1985 Apr; 10(4):327-31. PubMed ID: 3998042
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combined passive-active immunization against the hepatitis B virus of 132 newborns of chronic carrier mothers: long term results.
    Delage G; Rémy-Prince S; Ducic S; Pierri E; Montplaisir S
    Pediatr Infect Dis J; 1988 Nov; 7(11):769-76. PubMed ID: 2976491
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Persistence of antibodies after immunization with a recombinant yeast-derived hepatitis B vaccine following two different schedules.
    Scheiermann N; Gesemann M; Maurer C; Just M; Berger R
    Vaccine; 1990 Mar; 8 Suppl():S44-6; discussion S60-2. PubMed ID: 2139282
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A hepatitis B vaccination programme for inner metropolitan Sydney neonates.
    Reznik RB
    Med J Aust; 1991 Aug; 155(3):153-6. PubMed ID: 1831525
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatitis B vaccine in the EPI schedule.
    Jain AK; Mittal SK; Ramji S; Chakravarti A
    Indian J Pediatr; 2005 Aug; 72(8):661-4. PubMed ID: 16131770
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immune response to hepatitis B vaccine in newborns.
    Prozesky OW; Stevens CE; Szmuness W; Rolka H; Harley EJ; Kew MC; Scholtz JE; Mitchell AD
    J Infect; 1983 Jul; 7 Suppl 1():53-5. PubMed ID: 6674370
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rapid loss of vaccine-acquired hepatitis B surface antibody after three doses of hepatitis B vaccination in HIV-infected persons.
    Mizusawa M; Perlman DC; Lucido D; Salomon N
    Int J STD AIDS; 2014 Mar; 25(3):201-6. PubMed ID: 24216032
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine.
    Carne CA; Weller IV; Waite J; Briggs M; Pearce F; Adler MW; Tedder RS
    Br Med J (Clin Res Ed); 1987 Apr; 294(6576):866-8. PubMed ID: 3105779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.